Aehr’s AI orders face tonight’s annual-sales test

Tonight, the order book meets the income statement

Aehr Test Systems enters Monday, November 2, with an unusually clear question: are its AI testing orders turning into sales fast enough to support management’s growth outlook? The semiconductor test-equipment company is scheduled to release fiscal first-quarter 2027 results after the U.S. close, followed by a 5 p.m. ET call. No results from that report are known here. [1][3]

The event follows an October 29 announcement appointing former Meta infrastructure executive Vijay Rao to the board, effective October 28. That adds relevant experience, but the announcement does not establish that Meta is Aehr’s unnamed hyperscale customer or has signed a new supply agreement. Keeping those claims separate matters more than the AI label. [5]

What the latest completed session actually showed

AEHR closed Friday, October 30, at US$54.89, down US$6.32 from Thursday’s US$61.21, a 10.33% fall. Yahoo’s historical daily bar shows 2,659,800 shares traded versus a 2,639,995-share average over the preceding 20 sessions: 1.01 times normal on that defined measure. These are Friday figures, not a live Monday price. [2]

The decline was not isolated. Semiconductor test names Teradyne and Cohu fell 7.38% and 4.89%; Intel dropped 28.58%. Intel’s October 29 release warned that the PC slowdown could continue through the first half of next year. That helps explain the sector’s nervous backdrop, without proving Intel caused every move in Aehr. [6][7][8][16]

The growth promise—and the timing catch

Aehr’s July 14 release projected fiscal 2027 revenue of US$130 million–US$150 million and non-GAAP net income of 18%–22% of revenue. The sales midpoint is US$140 million, or 2.8 times fiscal 2026 revenue of US$50 million. That is a forecast comparison, not growth already delivered, and the fiscal year-end changed from May to June. [1][3]

The October 7 orders cover Sonoma package-level burn-in systems, modules, sockets and software for a hyperscale customer’s second AI processor program. Aehr said deliveries were scheduled over six months and the device’s production ramp was expected in calendar 2027. Orders, deliveries and recognized revenue therefore need not land in the same quarter. [4]

That distinction is tonight’s central business test. The report covers June 27–September 25, after Aehr shifted its calendar. October’s order announcement falls after that quarter-end; it cannot simply be inserted into first-quarter sales. Likewise, July’s effective backlog is a dated measure, not a freshly verified November balance. [1][3][4]

What it means for option sellers

Cboe’s last available 30-day implied-volatility estimate was 116.433%, rounded here to 116.43%. Retrieved November 2 at about 6:10 a.m. EST, the feed still carried an underlying last-trade stamp of October 30 at 15:59:59. This delayed estimate is not a live Monday option quote. IV rank was not verified; check live prices before trading. [9]

For the wheel—selling cash-secured puts, then potentially covered calls on assigned shares—the important issue is the earnings gap. Elevated IV describes option pricing, not protection against a large stock decline. Volatility can fall after an event, but that does not guarantee a short option profits if the shares move sharply against it. [10][11][17]

• Business check: compare actual sales, margins and updated guidance with management’s July baseline. [3]
• Timing check: distinguish customer qualifications, firm orders, shipments and revenue; do not infer the unnamed customer’s identity. [4][5]
• Management scenario: reassess assignment economics after new disclosures rather than treating another premium as an automatic repair. [10][11]

What to watch next

• November 2, after close; 5 p.m. ET call: first-quarter results and any updated annual outlook. [1]
• November 3: the first regular session after the report, when the price reaction and new option spreads can be assessed. [1][18]
• November 6, 8:30 a.m. ET: October U.S. employment data. The Fed held its target range at 3.75%–4.00% on October 28; the jobs release is a fresh macro checkpoint, not a known outcome. [12][13]

Photo: 2x910 / Wikimedia Commons, CC BY-SA 4.0. Archival 2019 silicon-wafer photograph, cropped/resized under the same license; generic context, not an Aehr product or facility. [14][15]

Educational news, not personal investment advice. Options can cause substantial losses; forecasts and delayed prices can change.